migores1

TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024

VaselineAugust 17, 2024

0 1 minute read

TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024

TNXP Stock - TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024

Source: iQoncept / Shutterstock

Tonix Pharmaceuticals (NASDAQ:TNXP) just reported results for the second quarter of 2024.

Tonix Pharmaceuticals reported -$19.28 earnings per share. This was below the analyst estimate for EPS of -$7.20.
The company reported revenue of $2.21 million.
This was 34.09% worse than analysts’ estimate for revenue of $3.35 million.

InvestorPlace Earnings is a project that uses data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways, including earnings per share and revenue, as well as how a company measures up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers about the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected].

Print article from InvestorPlace Media, https://investorplace.com/earning-results/2024/08/tnxp-stock-earnings-tonix-pharmaceuticals-for-q2-of-2024/.

VaselineAugust 17, 2024

0 1 minute read

Vaseline

Related Articles

Warren Buffett bought $9.2 billion of this stock last year, but suddenly he’s no longer interested

TJX Beats Q2 Top and Bottom Estimates, Raises Full-Year Guidance; shares by Investing.com

Where will the stock of cava be in 5 years?

The medical stop loss report shows an increase in the frequency of requests for neoplasms